Found 54 matching trials
Phase 3 Boosting Study for the SARS-CoV-2 rS Vaccine PHASE3 This is an observer-blinded Phase 3 study to evaluate the safety and immuno...
Show More Location
Cleveland Clinic Abu Dhabi
Learn More & Join Trial
Phase 3 Pivotal Trial of NanoFlu™ in Older Adults PHASE3 A Phase 3, randomized, observer-blinded, active-controlled trial to evaluat...
Show More Learn More & Join Trial
A Study to Assess the Safety and Immunogenicity of the Malaria Vaccine, R21, With Matrix-M1 Adjuvant PHASE1 This is a study in which healthy adult volunteers will be given either an e...
Show More Location
Centre National de Recherche et de Formatation sur le Paludisme (CNRFP)/Unite de Recherche Clinique de Banfora (URC-B)
Learn More & Join Trial
Phase 3 Adolescent Study for SARS-CoV-2 rS Variant Vaccines PHASE3 This study is a large-scale investigation (Phase 3) into a new booster shot...
Show More Location
Alfa Medical Research
Learn More & Join Trial
Assessing the Safety, Immunogenicity and Ex-vivo Efficacy of Two Candidate Malaria Transmission Blocking Vaccines, Pfs25-IMX313 and Pfs45/48 Administered Alone and in Combination, in Matrix-M Adjuvant PHASE1 Assessing the safety, immunogenicity and ex-vivo efficacy of two transmissi...
Show More Status
Active Not Recruiting
Location
Institut des Sciences et Techniques (INSTech)
Learn More & Join Trial
A Study to Determine if New Types of Malaria Vaccines Are Safe, Effective and Lead to Immunity in Kenyan Adults PHASE2 This is a phase IIb clinical trial in malaria-exposed individuals to assess...
Show More Location
KEMRI/Wellcome Trust Programme, Centre for Geographic Medicine Research - Coast
Learn More & Join Trial
Evaluation of the Safety and Immunogenicity of a Recombinant Trivalent Nanoparticle Influenza Vaccine With Matrix M-1 Adjuvant (NanoFlu) PHASE1 This was a Phase 1/2, randomized, observer-blinded, active-controlled trial...
Show More Location
Research Site US108
Learn More & Join Trial
Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS Nanoparticle Vaccine With/Without Matrix-M Adjuvant PHASE1 2019nCoV-101 is a 2-part, randomized, observer-blinded, placebo-controlled,...
Show More Location
Meridian Clinical Research-(Savannah Georgia) - Platinum - PPDS - Phase 2
Learn More & Join Trial
Evaluation of the Safety and Immunogenicity of SII Vaccine Constructs Based on the SARS-CoV-2 (COVID-19) Variant in Adults PHASE1 This is a randomized, observer-blinded, Phase 1/2 study with an open-label ...
Show More Location
Australian Clinical Research Network (ACRN)
Learn More & Join Trial
Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above. PHASE1 The study aims to evaluate an egg-based H5N8 influenza vaccine up to 3 dose...
Show More Location
Multiple Locations
Learn More & Join Trial